Trial record 2 of 1695 for:
Uterine Diseases: Clinical Trials
Deep Dive Randomized Control Trial
This study has been completed.
Sponsor:
Health Dialog
Collaborators:
Health Net California
Highmark Blue Cross Blue Shield
Information provided by:
Health Dialog
ClinicalTrials.gov Identifier:
NCT00793260
First received: November 17, 2008
Last updated: November 18, 2008
Last verified: November 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Compare two care management support program models on medical costs and utilization.
| Condition | Intervention |
|---|---|
|
Chronic Disease Arthritis Uterine Diseases Spinal Diseases Preventive Health Services |
Behavioral: Enhanced Support Behavioral: Usual-Support |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Subject) |
| Official Title: | Deep Dive Randomized Control Trial |
Resource links provided by NLM:
MedlinePlus related topics:
Coping with Chronic Illness
Spine Injuries and Disorders
Uterine Diseases
U.S. FDA Resources
Further study details as provided by Health Dialog:
Primary Outcome Measures:
- The primary outcome measure was total medical costs (capped at $200,000 per individual per year) and pharmacy costs. [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Secondary measures included utilization of selected services. [ Designated as safety issue: No ]
| Enrollment: | 174120 |
| Study Start Date: | July 2006 |
| Study Completion Date: | May 2008 |
| Primary Completion Date: | June 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Usual Support Group
Predictive models in the Usual-Support Group were aimed at identifying individuals through medical claims and administrative data (such as hospitalization notification). The output of the predictive models is a rank-ordered, or stratified, list of individuals who have support needs. These lists were then used to generate outbound mail, interactive voice response (IVR) calls or calls by health coaches.
|
Behavioral: Usual-Support
Predictive models in the Usual-Support Group were aimed at identifying individuals through medical claims and administrative data (such as hospitalization notification). The output of the predictive models is a rank-ordered, or stratified, list of individuals who have support needs. These lists were then used to generate outbound mail, interactive voice response (IVR) calls or calls by health coaches.
|
|
Experimental: Enhanced Support Group
The Enhanced-Support Group intervention used more sophisticated predictive models, more extensive outreach to engage individuals, and provided tighter feedback loops to inform the care support process.
|
Behavioral: Enhanced Support
The Enhanced-Support Group program used lower risk thresholds for targeted outreach of individuals with chronic illness and for those likely to face discrete surgical interventions. Individuals at high financial risk but without one of the five chronic conditions were included in the Enhanced-Support Group. The Enhanced-Support Group received up to five initial reach attempts while the Usual-Support Group received up to three attempts. The Enhanced-Support Group used a 'tight loop' management structure including detailed, timely coach level feedback reports on efficiency and effectiveness. |
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- All employees, dependents and retirees in one of seven large employer groups, including a state university system, a state employee group, two manufacturing companies, a natural resource extraction company, a public educational service agency, and a nonprofit multiple employer association for independent colleges were eligible for inclusion.
Exclusion Criteria:
- no financial information was available from their facility and professional claims;
- they were in an employer sub-group ineligible for care support services;
- they asked not be to contacted or were deceased;
- gender information was missing from their eligibility files;
- their claims data from the year prior to the start of the study indicated diagnoses of HIV, AIDS, end-stage renal disease (ESRD), organ transplants, or necrotizing fasciitis (intended to improve the likelihood of a balanced distribution of costs and conditions); OR
- they were in an employer sub-group with less than four months of enrollment prior to the study start date (resulting in too little information for stratification).
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00793260
Locations
| United States, Maine | |
| Health Dialog Analytic Solutions, Inc | |
| Portland, Maine, United States, 04101 | |
Sponsors and Collaborators
Health Dialog
Health Net California
Highmark Blue Cross Blue Shield
Investigators
| Principal Investigator: | David E Wennberg, MD, MPH | Health Dialog |
More Information
No publications provided by Health Dialog
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | David E. Wennberg, MD, MPH / Chief Science & Products Officer, Health Dialog Analytic Solutions, Inc |
| ClinicalTrials.gov Identifier: | NCT00793260 History of Changes |
| Other Study ID Numbers: | DeepDive |
| Study First Received: | November 17, 2008 |
| Last Updated: | November 18, 2008 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Arthritis Chronic Disease Spinal Diseases Uterine Diseases Joint Diseases |
Musculoskeletal Diseases Disease Attributes Pathologic Processes Bone Diseases Genital Diseases, Female |
ClinicalTrials.gov processed this record on May 16, 2013